Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Probiotic and Vitamin D Supplementation in Modulating Gut Dysbiosis, Nutrition, Inflammation and Immune Status and Reduce Risk of COVID-19 in Obese People: Gut-Lung Axis Randomized Trial

NCT04979065 is registered in ClinicalTrials.gov with Indonesia University as lead sponsor.

NCT NCT04979065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04979065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Probiotic and Vitamin D Supplementation in Modulating Gut Dysbiosis, Nutrition, Inflammation and Immune Status and Reduce Risk of COVID-19 in Obese People: Gut-Lung Axis Randomized Trial
Lead sponsor
Indonesia University
Phase
Phase 2
Overall status
Completed
Start date
July 24, 2021
Completion date
December 30, 2022
Enrollment
93 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, immune deficiency, overweight and obesity, vitamin d deficiency